2022 was a really weird year to be an investor. Even four years later, I still remember what happened. A lot of investors were panicking because their supposedly balanced 60/40 portfolios of…
Tony Dong The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every healthcare…
Healthcare is supposed to be the place you hide. It is the fourth-largest slice of U.S. GDP at 8.9% in the fourth quarter of 2025, growing at 1.5% while construction and transportation…
Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT), a pure-play sector fund that has quietly compounded wealth for long-term investors…
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of healthcare’s standout performers over the past year, with shares up 48% over the past 12 months and 16% year-to-date. The…
Recession fears are rising, AI is reshaping the labor market, and retirees face a danger most investors overlook: being forced to sell at the worst possible moment. Five low-cost ETFs, each under…
Healthcare isn’t going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions. Health Care Select Sector SPDR Fund (NYSEARCA:XLV) offers concentrated exposure…
Austin Smith Index investors and so-called Bogleheads (those who love the Vanguard ETFs) may not be all too fond of the sector ETFs, especially when you consider that simply buying the S&P 500 covers…
Healthcare is supposed to be defensive. When tech stocks swing wildly and consumer spending wobbles, healthcare companies keep selling drugs, performing surgeries, and processing insurance claims. That steady demand makes the sector…
Defensive stocks are defined as the stocks in companies that are grouped in sectors supplying goods and services in constant demand as essentials, and thus, do not follow trends of popularity. Defensive…
If you are an investor who is securing profits and is buying up dividend ETFs to weather a possible downturn instead, it’s not a bad idea to look back at the past…
The JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) has become a go-to for investors chasing steady income with a side of equity exposure. Currently trading under $58 per share, the exchange-traded fund hauled…
If you’re 35 and growing a bit anxious about the prospect of retirement, do not fret as many Millennials, some of whom are living paycheck to paycheck and burdened by student loans,…
Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments due to his comments.
thinkstockInvestors almost always worry about a stock market crash, but when headwinds start to look stronger than the positive forces, they really start to worry that the rug can get yanked right…
